PMC Income Statement - TTM - Pharmedic Pharmaceutical Medicinal Joint Stock Company

Income Statement (TTM)

Pharmedic Pharmaceutical Medicinal Joint Stock Company Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2021 01-01	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	457,843	460,764	448,821	470,852	404,788	414,232	414,456	408,974	484,469	472,274	458,682	455,205	479,794	485,186	483,237	516,738	493,367	498,185	522,630	517,711
Change (%)		0.64	-2.59	4.91	-14.03	2.33	0.05	-1.32	18.46	-2.52	-2.88	-0.76	5.40	1.12	-0.40	6.93	-4.52	0.98	4.91	-0.94
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	279,043	284,276	278,658	295,495	262,657	266,740	262,218	254,608	292,686	285,918	282,036	285,144	310,797	315,134	314,023	336,395	311,612	310,972	316,534	305,168
Change (%)		1.88	-1.98	6.04	-11.11	1.55	-1.70	-2.90	14.96	-2.31	-1.36	1.10	9.00	1.40	-0.35	7.12	-7.37	-0.21	1.79	-3.59
% of Revenue	60.95	61.70	62.09	62.76	64.89	64.39	63.27	62.26	60.41	60.54	61.49	62.64	64.78	64.95	64.98	65.10	63.16	62.42	60.57	58.95

Gross Operating Profit	178,800	176,488	170,163	175,357	142,130	147,492	152,238	154,366	191,783	186,356	176,645	170,061	168,997	170,053	169,214	180,343	181,754	187,213	206,097	212,542
Change (%)		-1.29	-3.58	3.05	-18.95	3.77	3.22	1.40	24.24	-2.83	-5.21	-3.73	-0.63	0.62	-0.49	6.58	0.78	3.00	10.09	3.13
% of Revenue	39.05	38.30	37.91	37.24	35.11	35.61	36.73	37.74	39.59	39.46	38.51	37.36	35.22	35.05	35.02	34.90	36.84	37.58	39.43	41.05

SG&A	92,709	90,801	87,837	89,343	73,717	74,912	77,439	79,213	96,812	95,588	91,178	87,292	85,205	85,645	85,717	89,257	89,329	96,729	106,195	112,856
Change (%)		-2.06	-3.26	1.72	-17.49	1.62	3.37	2.29	22.22	-1.26	-4.61	-4.26	-2.39	0.52	0.08	4.13	0.08	8.28	9.79	6.27
% of Revenue	20.25	19.71	19.57	18.97	18.21	18.08	18.68	19.37	19.98	20.24	19.88	19.18	17.76	17.65	17.74	17.27	18.11	19.42	20.32	21.80

R&D
Change (%)
% of Revenue

OpEx	371,752	375,077	366,494	384,839	336,374	341,652	339,656	333,821	389,498	381,506	373,214	372,437	396,002	400,779	399,765	425,652	400,941	407,701	422,711	418,025
Change (%)		0.89	-2.29	5.01	-12.59	1.57	-0.58	-1.72	16.68	-2.05	-2.17	-0.21	6.33	1.21	-0.25	6.48	-5.81	1.69	3.68	-1.11
% of Revenue	81.20	81.40	81.66	81.73	83.10	82.48	81.95	81.62	80.40	80.78	81.37	81.82	82.54	82.60	82.73	82.37	81.27	81.84	80.88	80.74

Operating Income	86,092	85,687	82,326	86,013	68,414	72,580	74,800	75,153	94,971	90,768	85,467	82,768	83,791	84,408	83,472	91,086	92,425	90,484	99,920	99,686
Change (%)		-0.47	-3.92	4.48	-20.46	6.09	3.06	0.47	26.37	-4.43	-5.84	-3.16	1.24	0.74	-1.11	9.12	1.47	-2.10	10.43	-0.23
% of Revenue	18.80	18.60	18.34	18.27	16.90	17.52	18.05	18.38	19.60	19.22	18.63	18.18	17.46	17.40	17.27	17.63	18.73	18.16	19.12	19.26

Interest Expense	-14																			-43
Change (%)
% of Revenue	-0.00																			-0.01

Net Income	75,194	74,618	71,329	75,019	59,644	64,760	65,911	67,529	84,866	83,416	80,097	81,481	81,865	83,564	83,105	84,344	85,071	80,133	88,132	86,315
Change (%)		-0.77	-4.41	5.17	-20.49	8.58	1.78	2.46	25.67	-1.71	-3.98	1.73	0.47	2.08	-0.55	1.49	0.86	-5.80	9.98	-2.06
% of Revenue	16.42	16.19	15.89	15.93	14.73	15.63	15.90	16.51	17.52	17.66	17.46	17.90	17.06	17.22	17.20	16.32	17.24	16.09	16.86	16.67

Source: Capital IQ

Pharmedic Pharmaceutical Medicinal Joint Stock Company - Income Statement (TTM)

Income Statement (TTM)